RxDoctor Payments Data

Ashley Shivers

Family · Morton, MSNPI 1184958753

Payments from drug & device makers

$705in general payments, 2019–2025

Across 41 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$321
  • Novo Nordisk$114
  • Lilly USA, LLC$80
  • Boehringer Ingelheim$42
  • Merck$35
  • Phathom Pharmaceuticals, Inc.$24
  • plus $90 from 5 others

What the payments were for

  • Food & beverage$705100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$705 in reported general payments places this provider in the 60th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$761
Medicare patients
14
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin84$59,155
MounjaroTirzepatide50$55,888
OzempicSemaglutide29$26,865
EliquisApixaban32$26,479
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$25,737
RybelsusSemaglutide22$20,778
TradjentaLinagliptin26$18,034
JanuviaSitagliptin Phosphate22$16,881
FarxigaDapagliflozin Propanediol26$13,451
LinzessLinaclotide20$13,222
XareltoRivaroxaban17$13,130
MyrbetriqMirabegron16$13,000
TrulicityDulaglutide14$11,603
SymbicortBudesonide/Formoterol Fumarate21$7,484
TrulancePlecanatide11$5,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$42$77,189110 claims
Lilly USA, LLCMounjaro, Trulicity$80$67,49164 claims
Novo NordiskOzempic, Rybelsus$114$47,64351 claims
MerckJanuvia$35$16,88122 claims
AbbVieLinzess, Synthroid$321$13,78934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,007 family providers in Mississippi.

Other family in Morton

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →